MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$445,745K
Unrealized gains on
marketable securities, net
$469K
Interest income
$29,859K
Net loss
-$446,214K
Total other income,
net
$21,970K
Interest expense
$6,192K
Other expense, net
-$1,697K
Loss from operations
-$468,184K
Total operating
expenses
$468,184K
Research and development
$398,333K
General and
administrative
$69,851K
Back
Back
Income Statement
source: myfinsight.com
Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN)